Abstract:Objective To summarize the clinical quality control data of hemodialysis patients and analyze the current treatment status to provide evidence for further clinical treatment. Methods The cross-sectional study of clinical quality control data was conducted in 72 maintenance hemodialysis patients treated in Nanjing Nangang Hospital from December 2016 to December 2017. The overall standard-reaching status of clinical quality control indicators was grasped, and the impact of diabetic nephropathy and dialysisadequacy on clinical quality control indicators was analyzed. Results The clinical quality control indicators presented that the standard-reaching rates of solute clearance [urea reduction rate (URR) more than 65%], blood pressure, hemoglobin (Hb) level, nutritional index [serum albumin(ALB)], serum Ca²⁺, serum P^3-, total parathyroid hormone(iPTH), micro inflammation index [C reactive protein (CRP)] were 47.22%, 61.11%, 45.83%, 73.61%, 52.78%, 58.33%, 44.44% and 76.38% respectively. In diabetic nephropathy patients, the levels of iPTH, serum P^3-, Hb and ALB decreased significantly, and the CRP level increased compared with non-diabetic nephropathy patients(P<0.01, P<0.05). There were significant differences in the levels of iPTH, P^3-, ALB and Hb between the patients with dialysis adequacy(URR>65%) and the patients with dialysis inadequacy(URR<65%)(all P<0.01). Conclusion In maintenance hemodialysis patients, anemia and malnutrition are more likely to occur in diabetic nephropathy patients, and dialysis adequacy is an important factor affecting iPTH level, calcium and phosphorus metabolism, nutritional status and anemia. It is necessary to improve dialysis adequacy based on the monitoring of clinical quality control indicators. According to different primary diseases and abnormality of detection indexes, individualized treatment should be performed to reduce complications and improve the quality of life of patients.